🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2007-10-10
Trial ID
NCT00543504
Treatments Being Tested
PURPOSE: This randomized phase III trial is studying maintenance therapy wi...
Status
Completed
Location
LKH Leoben
Start Date
2005-05
Trial ID
NCT00265824
Treatments Being Tested
Patients with metastatic colorectal cancer will be treated with chemotherap...
Status
Completed
Location
University Hospital
Start Date
2010-10
Trial ID
NCT01229813
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Kaiser Permanente - Deer Valley
Start Date
2007-07
Trial ID
NCT00436332
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2009-07-07
Trial ID
NCT00720356
Treatments Being Tested
This trial will investigate the combination of bevacizumab, and erlotinib i...
Status
Completed
Location
Multiple Locations
Start Date
2004-04
Trial ID
NCT00193622
Treatments Being Tested
Multicenter randomized phase II trial to examine the safety and efficacy of...
Status
Completed
Location
Northeast Alabama Medical Center
Start Date
2007-12
Trial ID
NCT00621049
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center - Cool Springs
Start Date
2004-09
Trial ID
NCT00466687
Korean data of treating EGFR mutation positive NSCLC patients with Erlotini...
Status
Unknown
Location
National Cancer Center
Start Date
2016-11-01
Trial ID
NCT03126799
Treatments Being Tested
Pancreatic cancer is an aggressive, largely chemo-resistant disease with a ...
Status
Completed
Location
The Royal Marsden Foundation Hospital NHS Trust
Start Date
2005-11
Trial ID
NCT00260364